We Think Graphite Bio (NASDAQ:GRPH) Can Afford To Drive Business Growth – Yahoo Finance
Even when a business is losing money, it’s possible for shareholders to make money if they buy a good…
Oil flirts with 3-year highs: Lock in these stable 5%+ yields before they disappear
Recent oil price strength could be a timely income opportunity.
How One Weed Company Is Skirting Marijuana Rules to Sell THC Products in All 50 States – Rolling Stone
Marijuana is federally illegal. But what if you could get high off hemp?
Dutch protesters march through The Hague against ‘corona pass’ – The Guardian
PM sacks minister who questioned new policy requiring proof of vaccination or negative test in public venues
Investing in Cousins Properties (NYSE:CUZ) a year ago would have delivered you a 43% gain
Diversification is a key tool for dealing with stock price volatility. But the goal is to pick stocks that…
Kunal Bothra’s 3 stock picks for the week ahead
I think this week has been spectacularly positive for the index right from the word go. Some of the…
S&P 500, DAX 40, FTSE 100, Technical Forecasts for the Week Ahead
Global stocks bounce back from recent pullback as key resistance levels lie ahead.
D.R. Horton: Buy, Sell, Or Hold? The Ins And Outs Of The Housing Market
New home demand is booming and inventory of existing homes is tight. However, supply constraints, labor shortages, and sticker…
Play real estate rebound with cement, ceramic, tiles stocks
Higher infrastructure spending by the government, an upturn in housing construction and an overall improvement in the macroeconomic…
FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Heterozygous Familial Hypercholesterolemia
Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Repatha® (evolocumab) as an…
recent post
-
Jan 27 2026 -
Jan 27 2026
-
Jan 27 2026
-
-
Jan 27 2026
